Semaglutide and liraglutide may reduce alcohol consumption in individuals with AUD owenhaskins Nov 14, 2024 2 min read A joint study by the University of Eastern Finland and Karolinska Institutet in Sweden has found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with fewer hospitalisations among individuals with alcohol use disorder (AUD)
Research Observation: A 2025 review specifically examined its effect on GLP-1 and insulin secretion, identifying the bacterium's capacity to stimulate GLP-1 production as a key mechanism
Older Americans have been waiting for access to the same standard of care that is increasingly available in commercial plans, and for the first time a pathway has opened to provide that access
The chemical structure of the MSNs-ss-SA was further characterized using C magic angle spinning nuclear magnetic resonance (C MAS NMR) spectroscopy on a Bruker AVANCE III 400 WB spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) at 400 MHz, with a 4 mm rotor spinning at 6.5 kHz
The internet is typically a treasure trove of websites that sell such substances and compounds internationally, at prices that are affordable and easy on the pocket
